tiprankstipranks
Trending News
More News >
Longboard Pharmaceuticals, Inc. (LBPH)
:LBPH
US Market
Advertisement

Longboard Pharmaceuticals (LBPH) Similar Stocks

Compare
Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Longboard Pharmaceuticals
66.84%
Curis
$1.80
$21.60M
-72.27%
3 Buy
0 Hold
0 Sell
Strong Buy
Bioxcel Therapeutics
$1.91
$11.51M
-89.80%
2 Buy
0 Hold
1 Sell
Moderate Buy
Kiniksa Pharmaceuticals
$29.02
$2.07B
37.15%
5 Buy
0 Hold
0 Sell
Strong Buy
Aquestive Therapeutics
$4.20
$400.29M
31.25%
7 Buy
0 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$15.48
$1.84B
50.46%
7 Buy
0 Hold
0 Sell
Strong Buy
Pliant Therapeutics
$1.42
$82.26M
-88.43%
1 Buy
5 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LBPH
Longboard Pharmaceuticals
59.98
24.03
66.84%
CRIS
Curis
1.80
-4.69
-72.27%
BTAI
Bioxcel Therapeutics
1.91
-16.81
-89.80%
KNSA
Kiniksa Pharmaceuticals
29.02
7.79
36.69%
AQST
Aquestive Therapeutics
4.20
1.00
31.25%
ARQT
Arcutis Biotherapeutics
14.67
4.92
50.46%
PLRX
Pliant Therapeutics
1.43
-10.93
-88.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis